dementia glp-1 Popular obesity drug fails in hotly anticipated Alzheimer's trials | Science GLP-1 Drugs Target the Roots

New research has lent weight to the intriguing idea that GLP-1 agonists may help people with substance use disorders break their addiction.

GLP-1 friendly

Understanding DoD policy, fitness standards, and how genetic predispositions influence medication tolerance can help guide informed conversations with military medical providers about s

The native Glucagon-like peptide-1 (GLP-1) plays a crucial role in regulating blood sugar and appetite, and its natural production can be enhanced through di...

Calculate peptide dosages, reconstitution volumes and injection amounts quickly with this easy-to-use peptide calculator.

They lost about 8% of their body weight in 24 weeks.1 Individuals who gained back some weight after surgery lost almost 9% of their body weight after six months of taking liraglutide or semaglutide.2 People who had surgery and started gaining weight again lost about 10-15% of their weight after six months of taking semaglutide or tirzepatide.3 In summary, obesity is a complex disease that requires a variety of tools to manage it long-term